The company will not receive any of the proceeds from the sale of the shares by the selling stockholder.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EKSO:
- Ekso Bionics’ Earnings Call: Growth Amid Challenges
- Ekso Bionics price target lowered to $1 from $2 at Lake Street
- Ekso Bionics: Strategic Partnerships and Financial Health Drive Buy Rating with $9 Price Target
- Ekso Bionics Reports Record Q4 Revenue and Strategic Partnership
- Ekso Bionics reports Q4 EPS (14c) vs. (22c) last year